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The typical view of estrogen is that it is associ-
ated with a reduction in food intake, fat depo-
sition, and body weight in adults (Cooke and
Naaz 2004). However, a maxim in develop-
mental biology and pediatric medicine is that
it is inappropriate to use effects in adults to
predict effects during development (i.e., babies
are not little adults) (National Research
Council 1993). During critical periods in
development, estrogenic drugs and chemicals
can have unexpected stimulatory effects on the
differentiation of adipocytes, as well as on
postnatal growth and obesity (Cooke and Naaz
2004; Howdeshell et al. 1999; Newbold et al.
2005). There is also an extensive literature
showing that administration of supplementary
estrogen to rodents, even at very low doses,
disrupts normal development of the reproduc-
tive system (Welshons et al. 2003, 2006). The
administration of diethylstilbestrol (DES) to
millions of women, and experiments in mice
showing a high concordance in pathologic out-
come, revealed that mice are appropriate sen-
tinels for studies of the effects of estrogen on
development in humans (Newbold 1995;
Swan and vom Saal 2001).
The prediction that obesity and other
abnormalities are related to events (e.g., alter-
ations in fetal hormone levels due to maternal
stress, maternal nutrition, or exposure to
environmental chemicals) that occur during
fetal development is know as the “fetal basis
of adult disease” hypothesis. For example,
there is now considerable evidence that meta-
bolic syndrome in humans is related to
factors that influence growth in utero.
Specifically, intrauterine growth restriction
(IUGR) that is followed by a high velocity of
postnatal growth results in adult obesity and
associated metabolic diseases. The “thrifty
phenotype” hypothesis predicts that this is
due to the inability of the IUGR individual’s
homeostatic systems that regulate body
weight to function when there is a high level
of energy intake common in developed coun-
tries (Wild and Byrne 2004; Yajnik 2001).
Endocrine changes are associated with obesity
(for example, there is an increase in the hor-
mone leptin that is produced by adipocytes),
and they not only impact the neuroendocrine
control of metabolic systems and appetite
(Kalra et al. 2005; Schwartz 2001), but they
also impact reproductive tissues and processes
(Baratta 2002). 
Although estrogenic drugs such as DES
and estrogenic environmental chemicals such
as bisphenol A (BPA) can profoundly disrupt
normal development at very low doses in rats
and mice (vom Saal and Welshons 2006;
Welshons et al. 2006), there remains much
controversy as to whether estrogenic chemicals
that are synthesized in plants are harmful or
beneficial. One basis for this controversy is
related to the issue of selective estrogen recep-
tor modulators—estrogens whose effects can
differ markedly in different tissues and at dif-
ferent times in life (Welshons et al. 2006). Soy
is the major source of plant-phytoestrogen
exposure in humans and in laboratory rodents,
which have been bred and maintained by
commercial animal breeders for many genera-
tions on soy-containing feed. This suggests
that laboratory rodents have been subjected to
selection for traits that allow them to tolerate
relatively high levels of phytoestrogens present
in the most commonly used commercial
soy-based feeds.
In the present study we compared mice
reared and maintained on a low- (non-soy)
and high-phytoestrogen–containing soy-based
feed. The objective was to determine the
effects on phenotype of eliminating soy phy-
toestrogens from feed, because all of our prior
research involving the effects of endocrine-
disrupting chemicals has been conducted with
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BACKGROUND: Although estrogenic chemicals can disrupt development of the reproductive system,
there is debate about whether phytoestrogens in soy are beneficial, benign, or harmful. 
OBJECTIVES: We compared reproductive and metabolic characteristics in male and female mice
reared and maintained on non-soy low-phytoestrogen feed or soy-based high-phytoestrogen feed.
METHODS: The low-phytoestrogen diet was non-soy PMI 5K96 (verified casein diet), and the high-
phytoestrogen diet consisted of soy-based PMI 5008 during pregnancy and lactation and soy-based
PMI 5001 maintenance feed after weaning.
RESULTS: In fetuses whose mothers consumed the low-phytoestrogen PMI 5K96 feed, we found a
paradoxical significant elevation in endogenous serum estradiol, which was associated postnatally
with adverse reproductive outcomes referred to as the “fetal estrogenization syndrome (FES)”. In
females, this syndrome included early puberty and increased uterine responsiveness to estrogen, and
in males, it included reduced testis, epididymis, and seminal vesicle size, but an enlarged prostate.
The low-phytoestrogen–fed males and females were lighter at birth, but, between weaning and
adulthood, they became obese and developed abnormally high serum leptin levels; these males, but
not females, showed impaired glucose regulation. 
CONCLUSIONS: Removing phytoestrogens from mouse feed produces an obese phenotype consistent
with metabolic syndrome, and the associated reproductive system abnormalities are consistent with
FES due to elevated endogenous fetal estradiol. Laboratory rodents may have become adapted to
high-phytoestrogen intake over many generations of being fed soy-based commercial feed; remov-
ing all phytoestrogens from feed leads to alterations that could disrupt many types of biomedical
research.
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animals maintained on soy-based Purina-Mills
(PMI; St. Louis, MO) feed. The basis for our
interest in this issue was a desire to avoid the
potential disruption of experiments concerning
the effects of estrogenic endocrine-disrupting
chemicals because of the marked variability in
phytoestrogen levels known to exist from one
batch of soy to another (Heindel and vom Saal
2008). Many environmental factors influence
phytoestrogen levels per gram of soy protein,
and diets with a constant level of soy protein
can show variable levels of phytoestrogens that
are great enough to disrupt studies of the
effects of DES in mice (Thigpen et al. 2003).
One logical assumption would thus be to elim-
inate this problem by using a soy-free feed. 
In contrast to our prediction, we found
that there is a paradoxical estrogenization of
fetuses that occurs when pregnant female
mice are fed a low-phytoestrogen, soy-free
feed because of an elevation in endogenous
fetal serum estradiol; this is related to adverse
postnatal reproductive traits similar to those
produced by exposing fetuses to estradiol,
DES, and other man-made estrogenic chemi-
cals such as BPA. In addition, the low-phyto-
estrogen feed produced a phenotype
consistent with metabolic syndrome. Our
findings suggest a dramatic difference in phe-
notype of mice exposed to plant phyto-
estrogens compared with estradiol or
man-made estrogenic drugs and chemicals,
which is consistent with other recent findings
(Dolinoy et al. 2007).
General Methods
Experimental animals and feeds. CD-1 mice
(Mus musculus domesticus) were purchased
from Charles River (Wilmington, MA) and
maintained as an outbred colony with periodic
replacement of breeder males and females.
Animals were housed in standard polypropy-
lene mouse cages on corncob bedding. Glass
water bottles were used, and water was puri-
fied by reverse osmosis and carbon filtration.
Rooms were kept at 23°C and maintained on
a 12-hr light and 12-hr dark cycle, with lights
on at 1100 hours so that timed matings could
occur at the end of the dark phase of the cycle.
All animal procedures were approved by the
University of Missouri Animal Care and Use
Committee and conform to the NIH Guide
for the Care and Use of Laboratory Animals
(Institute of Laboratory Animal Resources
1996). The animals were treated humanely
and with regard for alleviation of suffering.
We randomly selected adult female CD-1
mice from our colony (previously maintained
after weaning on PMI 5001) to be placed on
either PMI 5K96 or PMI 5008 for 7 days,
after which they were paired with males until
they were visibly pregnant. Females remained
on these diets throughout pregnancy and lacta-
tion. The number, weight, and sex of pups
were recorded on the day of birth. At weaning
on postnatal day (PND) 20, pups reared on
the PMI 5008 breeder chow were switched to
PMI 5001 maintenance chow, which has less
fat and metabolizable energy. The combined
use of PMI 5008/5001 is standard in many
laboratories. Pups reared on PMI 5K96 feed
remained on this feed after weaning. These
procedures for administering feeds were used
in all experiments, although the age at weaning
differed in a few experiments. The PMI 5K96
feed does not contain soy, and casein is one of
the sources of protein in this feed; Purina-Mills
describes PMI 5K96 as a “verified casein diet”
(LabDiet 2007). In contrast, the PMI 5008
and PMI 5001 feeds are soy based and thus
contain soy isoflavones. The components of
these different feeds are provided in Table 1. 
For postnatal studies, we weaned 18 for
the PMI 5008/5001 diet and 19 for the
PMI 5K96 diet. Average litter size at birth
was 13 pups, and there was no effect of feed
on litter size. At weaning, males and females
were separated and housed three or four per
cage unless otherwise noted. 
Estradiol radioimmunoassay. The estra-
diol radioimmunoassay was performed as pre-
viously described (vom Saal et al. 1990).
Briefly, [125I]estradiol and antisera were
obtained from ICN Biomedicals (Costa Mesa,
CA), and unlabeled estradiol was obtained
from Steraloids (Wilton, NH). Sensitivity of
the assay was 0.5 pg/tube. Intraassay and
interassay coefficients of variation were 5% and
4%, respectively. We determined the percent
cross-reactivity of the estradiol antiserum with
estrone to be 0.6%. Cross-reactivity with other
steroids was reported by ICN to be negligible. 
Leptin radioimmunoassay. Leptin levels
were measured in serum by radioimmuno-
assay (Linco leptin assay kit) according to the
manufacturer’s protocol (Linco Research
Immunoassay, St. Charles, MO). 
Statistical procedures. All organ weight
data were first analyzed by analysis of covari-
ance (ANCOVA) to determine whether organ
weight measures needed to be corrected for
body weight. If body weight accounted for a
significant component of the variance, then
group means were adjusted for body weight. If
body weight did not account for a significant
component of the variance for a specific meas-
ure, then the data were reanalyzed by analysis
of variance (ANOVA). With the exception of
the seminal vesicles, all other organs examined
were significantly correlated with body weight,
and these organ weight data were analyzed by
ANCOVA rather than ANOVA, with body
weight as the covariate. If more than one ani-
mal per litter was used in an experiment, litter
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Table 1. Percent components of soy-based PMI 5001 and 5008 feeds and non-soy PMI 5K96 feed and com-
ponents of these feeds that are present (+) or absent (–) in each type of feed.
PMI 5008 PMI 5001 PMI 5K96
Components of feeds
Percent protein 23.5 23.4 18.9
Percent fat (ether extract) 6.5 4.5 4.3
Percent fiber (crude) 3.8 5.3 3.6
Percent starch 34.9 31.9 44.8
Percent sucrose 2.6 3.7 0.4
Total digestible nutrients (%) 81.2 76 75.2
Gross energy (kcal/g) 4.15 4 4.05
Physiological fuel value (kcal/g) 3.5 3.3 3.44
Metabolizable energy (kcal/g) 3.31 3.04 3.15
Differences between feeds
Animal fat preserved with BHA + + –
Biotin – – +
Cane molasses + + –
Casein – – +
Corn gluten meal – – +
Corn oil – – +
Dehydrated alfalfa meal + + –
Dicalcium phosphate – – +
Dried beet pulp + + –
Dried whey + + –
Ferrous carbonate + + –
Ferrous sulfate – + –
Ground wheat + – +
Magnesium oxide – – +
Nicotinic acid – + –
Porcine meat meal + + –
MSB (vitamin K) + – +
Nicotinic acid + – +
MSB, menadione sodium bisulfite (source of vitamin K). Additional ingredients found in all diets: brewers dried yeast, cal-
cium carbonate, calcium iodate, calcium pantothenate, cholecalciferol, choline chloride, cobalt carbonate, copper sul-
fate, cyanocobalamin, dehulled soybean meal, dl-alpha tocopheryl acetate, DLmethionine, fish meal, folic acid, ground
corn, ground oats, manganous oxide, pyridoxine hydrochloride, riboflavin, salt, thiamin mononitrate, vitamin A acetate,
wheat middlings, zinc oxide, and zinc sulfate. Data from Labdiet (2007). 
was included as a main effect variable and the
F-value for the diet comparison was divided by
the F-value for litter. We conducted planned
comparisons using the LSmeans test (SAS
Institute Inc., Cary, NC) on results if the over-
all ANOVA or ANCOVA was statistically sig-
nificant. Results were considered statistically
significant at p < 0.05. All data are presented as
the mean and SE. 
Experimental Methods
and Results
MCF-7 human breast cancer cell bioassay to
determine estrogenic activity in feed. We
measured the estrogenic activity in the feed by
solvent (methanol) extraction and examina-
tion of the degree to which the extract stimu-
lated proliferation of human MCF-7 breast
cancer cells; this bioassay provides a highly
sensitive method for detecting estrogenic
activity in feed (Welshons et al. 1990, 2003).
Use of this bioassay to screen feeds for estro-
genic activity prior to use is necessary because
there can be significant batch-to-batch vari-
ability in soy isoflavones in soy-based feeds, as
well as variability in other estrogenic contami-
nants in feeds that do not contain soy. Briefly,
approximately 10,000 cells were seeded per
well of a 24-well plate on day 0 in phenol red-
free (estrogen-free) medium, fed on day 1
with the same medium, and then treated on
days 3–6 with the test media, with daily
medium changes. Test media for feeds con-
tained methanol extracts from feed. On day 7
the wells were washed twice with 1 mL
Hanks' balanced salt solution, and each well
was then assayed for DNA content. 
Total estrogenic activity is expressed as
parts per million equivalents of a reference,
genistein, which is the primary phytoestrogen
in soy, even though the total estrogenic activity
is due to other estrogenic compounds in addi-
tion to genistein. The standard curve was based
on triplicate assays, and extracted samples were
each added to three wells containing cells.
When apparent estrogenic activity was
observed, the sample was run a second time to
confirm the initial results and to examine
whether proliferation occurred with and with-
out addition of an antiestrogen (ICI 182,780)
to confirm an estrogenic mechanism for stimu-
lation of proliferation. In all samples tested in
this experiment, the antiestrogen inhibited all
proliferation observed above estrogen-free con-
trols that did not contain any extract from feed.
We found very low estrogenic activity for
the batch of PMI 5K96 feed (expressed as
genistein equivalent units; 3.9 ppm) compared
with the batches of PMI 5008 (40.0 ppm) and
PMI 5001 (25.8 ppm). Because the PMI 5K96
feed is not completely free of estrogenic activity,
it is referred to as a low-phytoestrogen feed,
although the source of the estrogenic activity
was not identified.
Serum estradiol in pregnant females and
fetuses. A separate group of 13 females fed
PMI 5K96 and 10 females fed PMI 5008 were
killed on gestation day (GD) 18 for analysis of
serum estradiol levels. These females were
paired with stud males for 4 hr each day at the
end of the dark phase of the light:dark cycle
and then examined for vaginal plugs, which
was GD0. Females from each feed group were
housed three per cage, and fetuses were deliv-
ered on GD18 (1 day before parturition).
Maternal and fetal blood samples were col-
lected for measurement of estradiol. Blood
from males and from females within each litter
was pooled, with each litter yielding one value
for male and one value for female fetuses.
On GD18 (1 day before parturition and
during differentiation of pre-adipocytes and
the reproductive system), serum estradiol levels
in fetuses whose mothers were fed PMI 5K96
feed were significantly elevated relative to levels
in the fetuses whose mothers were maintained
on PMI 5008 feed (Figure 1). We found no
differences in serum estradiol levels in the preg-
nant females on the PMI 5008 and PMI 5K96
feeds, suggesting that the feed affected estradiol
production by the fetuses, not the mothers.
The PMI 5K96 feed, with little estrogenic
activity and casein rather than soy protein with
isoflavones, thus had the paradoxical effect of
increasing exposure of mouse fetuses to the
potent endogenous estrogen estradiol.
Postnatal body weight, abdominal fat, and
serum leptin. To determine the rate of post-
natal growth, we weighed one randomly
selected male and female from each litter (iden-
tified by a toe clip) at birth and weaning and in
adulthood; weighing pups every day alters their
postnatal growth (Ruhlen RL, unpublished
data). Pups produced by PMI 5008-fed
females were significantly heavier at birth than
pups produced by PMI 5K96-fed females
(Figure 2). There was no effect of feed on body
weight on PND20 (weaning), whereas on
PND90 (adulthood), the PMI 5K96-fed males
and females were significantly heavier than
PMI 5008/5001-fed animals of the same sex;
adult males fed PMI 5K96 weighed 11% more
than males fed PMI 5008/5001, and females
fed PMI 5K96 weighed 27% more than
females fed PMI 5008/5001. There was thus a
reversal of the effect of feed type on prenatal
Ruhlen et al.
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Figure 2. Mean (+ SE) body weight of female pups
(A,C,E; n = 18 PMI 5008/5001; n = 19 PMI 5K96C) and
male pups (B,D,F; n = 18 PMI 5008/5001; n = 19
PMI 5K96C) at birth (PND1; E,F), weaning (PND20;
C,D), and adulthood (PND90; A,B). 
*p < 0.01. 
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Figure 3. Mean (+ SE) weight of gonadal (A) and renal (B) fat pads from 3-month-old males and females
(PMI 5008/5001, n = 10; PMI 5K96C, n = 9). 
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growth, which was significantly increased by
high-phytoestrogen–containing feed, and
post-weaning growth, which was reduced by
high-phytoestrogen–containing feed. Males
fed PMI 5008/5001, but not PMI 5K96,
were significantly heavier than females on the
same feed.
On PND90 we examined the fat pads asso-
ciated with the gonads (epididymal fat pads in
males and parametrial fat pads in females) and
with the kidneys (renal fat pads) in males and
females, which together represent abdominal
fat in mice. Mice fed PMI 5K96 throughout
life were obese compared with those fed
PMI 5008/5001 (Figure 3). Gonadal and renal
fat pads from males fed PMI 5K96 weighed
93% and 115%, respectively, more than those
of males fed PMI 5008/5001. Gonadal and
renal fat pads from females fed PMI 5K96
weighed 126% and 86%, respectively, more
than those of females fed PMI 5008/5001.
Serum leptin was increased 121% in
males and 174% in females fed PMI 5K96
compared with males and females fed
PMI 5008/5001 (Figure 4). Leptin is pro-
duced by adipocytes, and serum leptin was
significantly correlated (r = 0.79; p < 0.001)
with total weight of fat pads.
Adult glucose tolerance. We examined glu-
cose tolerance as previously described (Heine
et al. 2000). The same animals that were
examined for body weight, fat-pad weight,
and serum leptin were examined in this study,
which was conducted 1 week before fat pad
collection on PND90. Animals were fasted
overnight (12–14 hr), and injected intra-
peritoneally with 2 mg glucose per gram body
weight in 0.9% saline solution. Blood glucose
was measured with an Accu-Chek Glucometer
(Roche, Indianapolis, IN) by tail nick.
Linearity of the glucometer was verified with
the Accu-Chek Linearity Test Kit (Roche).
Basal blood glucose levels and glucose
clearance after a glucose injection were not
different based on type of feed in females. In
contrast, males fed PMI 5K96 had impaired
glucose clearance compared with males fed
PMI 5008/5001 (Figure 5). Specifically,
compared with males fed PMI 5008/5001,
basal blood glucose was significantly elevated in
males fed PMI 5K96 (p < 0.001); at both 60
and 90 min postglucose injection, blood glu-
cose was significantly higher in PMI 5K96-fed
males than in PMI 5008/5001-fed males. 
Uterine response to estradiol and serum
leptin in prepubertal females. The prepubertal
uterotrophic assay has been shown to be influ-
enced by exposure to estrogen during fetal–
neonatal development in mice, with develop-
mental exposure to low doses of estrogen
increasing uterine responsiveness to estrogen
(Newbold et al. 2004). In addition, the timing
of puberty in female mice can be accelerated
by females being maintained on a diet with
very high estrogenic activity after weaning
(Thigpen et al. 2003). This experiment thus
provides a means of determining whether the
uterine response to estradiol would be
enhanced in females being fed the soy-based
PMI 5001 feed containing high levels of phy-
toestrogens or PMI 5K96 with low-phyto-
estrogen levels that had resulted in elevated
endogenous estradiol levels during fetal life.
Two randomly selected females per litter
were weaned on PND17. The females were
anesthetized with isoflurane and implanted
subcutaneously with a Silastic capsule (0.62
i.d., 1.25 o.d.) that was 5 mm long between
the capped ends. One female from each litter
received a capsule contained 0.25 µg
17β-estradiol dissolved in 10 µL tocopherol-
stripped corn oil (Fisher Scientific, Pittsburgh,
PA). This dose of estradiol results in about
80% of the maximum uterine growth
response that can be induced with estradiol at
this age. The other females from the same lit-
ters (controls) were implanted with capsules
containing only oil vehicle. The capsules had
been preincubated for 24 hr in a physiologic
phosphate-buffered saline solution with albu-
min added to stabilize the rate of estradiol
release, which is then constant for the 3 days
of this experiment.
When examined on PND20, uterine wet
weight in females treated with the oil vehicle
did not differ based on diet. However, the
uteri of females fed PMI 5K96 were signifi-
cantly (p < 0.05) heavier in response to estra-
diol stimulation compared with those of
females fed PMI 5008/5001 (Figure 6). Body
weight was slightly, but not significantly,
higher in females fed PMI 5K96 (10.50 ±
0.49 g) relative to females fed PMI 5008/5001
(9.59 ± 0.45 g; p > 0.1). Neither feed nor
estradiol treatment influenced serum leptin,
which was about 2.2 ng/ml.
Body weight, uterine weight, histology, and
serum leptin on PND26. In this experiment,
10 females from each diet group were weaned
and weighed on PND19 and housed two or
three per cage; as in other experiments, the
PMI 5008 feed was replaced with PMI 5001.
On PND26 (around the time that puberty
would begin) the females were euthanized;
blood was collected for analysis of serum lep-
tin; body weight and uterine wet weight were
measured; and uteri were fixed for histologic
analysis of luminal epithelial cell height, which
was measured using Image Pro software
(Media Cybernetics, Bethesda, MD). These
uterine assays serve as biomarkers of whether
females were experiencing an increase in estro-
gen, indicating that puberty had begun. 
Longitudinal sections (7 µm) of the right
half of the uterus were mounted on poly-L-
lysein–coated glass slides stained with hema-
toxylin and eosin and examined using an
Olympus BH-2 light microscope (Olympus
Corp., New Hyde Park, NY) with Image Pro.
Adverse effects of phytoestrogen-free feed
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Figure 4. Mean (+ SE) serum leptin from 3-month-
old males (n = 7/group) and females (PMI 5008/5001,
n = 10; PMI 5K96C, n = 9). 
*p < 0.01.
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Figure 5. Mean (± SE) blood glucose before (time 0) and 30, 60, and 90 min after an intraperitoneal injection
of 2 mg/g glucose (in saline) in females (A) and males (B; n = 10/group) 1 week before sacrifice for exami-
nation of body fat and serum leptin on PND90. 
*p < 0.01.
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response to a low dose of estradiol or oil vehicle
via a subcutaneous Silastic implant (n = 10/group). 
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Uterine luminal epithelial cell height was
determined by calculating the average of three
measurements of randomly selected cells at
three nonadjacent sections in one uterine horn.
At weaning on PND19, the body weight
of PMI 5008 females was 10.0 ± 0.2 g and
that of PMI 5K96 females was 10.1 ± 0.3 g.
Compared with females on the PMI 5008/
5001 diets, PND26 females fed PMI 5K96
were significantly heavier and had significantly
enlarged uteri, increased epithelial cell height,
and significantly elevated serum leptin. Thus,
after consuming PMI 5K96 feed for 7 days
after weaning, mice fed PMI 5K96 had accel-
erated body growth and increased serum lep-
tin (suggesting an increase in body fat). The
PMI 5K96 feed stimulated an increase in both
uterine wet weight and epithelial cell height,
indicative of accelerated puberty in the
PMI 5K96-fed females compared with females
on the high-phytoestrogen PMI 5008/5001
feed (Figure 7).
Onset of fertility in females. Two randomly
selected females per litter were weaned on
PND20 and paired with a sexually experienced
male and monitored for the age at parturition.
When the female was visibly pregnant, the male
was removed. We recorded the age of the dam
at delivery and the number, body weights, and
sex ratio of pups. This procedure provides a
direct measure of the timing of onset of fertility
(the first ovulation and mating) as well as repro-
ductive capacity in peripubertal female mice. 
The females fed PMI 5K96 produced pups
at a significantly younger age (44.7 ± 0.3 days)
than the females fed PMI 5008/5001 (46.5 ±
0.6 days; p = 0.01). We found no significant
difference in the number of pups produced by
females on either feed, although the females
fed PMI 5K96 produced slightly more pups
per litter, and as a result, the litters tended to
weigh more (p = 0.06). 
Adult male reproductive organs. On
PND90, we collected reproductive organs
from male mice fed PMI 5K96 (n = 24) or
PMI 5008/5001 diets (n = 22). All male repro-
ductive organs were significantly different
based on the type of feed (Figure 8). The
weights of the testes and Wolffian duct–
derived organs (epididymides and seminal vesi-
cles) were significantly smaller in males fed
PMI 5K96 than in males fed PMI 5008/5001.
In contrast, for the prostate, which differenti-
ates from the urogenital sinus, males fed
PMI 5K96 had heavier prostates than those fed
PMI 5008/5001. In addition to reproductive
organs, males on the PMI 5K96 feed had a
smaller liver (2.08 ± 0.03 g) and a smaller right
kidney (298.9 ± 6.4 mg) than PMI 5008/5001
males (liver: 2.22 ± 0.03 g, p < 0.05; kidney:
354.7 ± 6.7 mg, p < 0.05). 
Discussion
A paradoxical finding in the present study was
that the low-phytoestrogen PMI 5K96 feed
resulted in a significant elevation in fetal
serum estradiol by 24% in males and 37% in
females compared with male and female
fetuses from dams on the high-phytoestrogen
soy PMI 5008 feed. We previously reported
that administration of estradiol to pregnant
mice that led to a similar elevation in fetal
serum estradiol, and also maternal administra-
tion of low doses of estrogenic drugs, pro-
duced an increase in prostate gland number
and size in male offspring maintained on
PMI 5008/5001 feed (Timms et al. 2005;
vom Saal et al. 1997). The finding that adult
males fed PMI 5K96 had enlarged prostates
compared to PMI 5008/5001-fed males is
thus consistent with these earlier findings, as
well as other reports that isoflavones are associ-
ated with a reduction in prostate size (Jensen
and Ritskes-Hoitinga 2007). 
We also previously reported that feeding
pregnant mice a low dose of BPA, the estro-
genic chemical used to make polycarbonate
plastic, resulted in exactly the same pattern of
reproductive organ differences in male off-
spring when examined in adulthood (small
testes, epididymides, and seminal vesicles, but
enlarged prostate) compared with untreated
males (vom Saal et al. 1998); this experiment
was also conducted with PMI 5008/5001-fed
male mice (Figure 9). Fetal exposure to a rela-
tively small increase in estradiol or man-made
estrogenic chemicals in the blood thus perma-
nently decreases testis, epididymis, and seminal
vesicle weight but through different mecha-
nisms increases prostate size (Nonneman et al.
1992; Richter et al. 2007; Timms et al. 2005;
vom Saal 1989; vom Saal et al. 1997). 
In females, exposure to estrogenic chemi-
cals such as BPA during fetal development
Ruhlen et al.
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Figure 8. Mean (+ SE) wet weight of testes (A), epidydimides (B), seminal vesicles (C), and prostates (D)
collected from 3-month-old male mice fed PMI 5K96C (n = 24) or PMI 5008/5001 (n = 22). With the exception
of the seminal vesicles, comparisons are based on ANCOVA, because for each organ measured, body
weight accounted for a significant component of the variance. 
*p < 0.05. **p < 0.01.
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Figure 9. Mean (+ SE) weight of reproductive organs in adult CF-1 male mice as a result of fetal exposure
to 2 µg/kg/day BPA. BPA or oil vehicle (controls) was fed to pregnant females on GD11–GD17. All pregnant
and lactating females were fed PMI 5008 and all males were fed 5001 after weaning. The effects of BPA on
the reproductive organs in male mice maintained on the PMI 5008/5001 feed was identical to the effects of
the PMI 5K96C feed compared with PMI 5008/5001 feed shown in Figure 8. This suggests that the elevation
in fetal serum estradiol caused by the PMI 5K96C feed (Figure 1) produced a permanent effect on the
reproductive organs in males, similar to the permanent effect caused by fetal exposure to BPA. Adapted
from vom Saal et al. (1998).
*p < 0.05. **p < 0.01. #p = 0.08. 
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Figure 7. Mean (+ SE) body weight (A), uterine weight (B), height of the uterine luminal epithelium (C), and
serum leptin (D) in females weaned on PND19 and examined on PND26. 
*p < 0.01.
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leads to an accelerated postnatal growth and
accelerated onset of puberty (Howdeshell et al.
1999). In the present study we found that on
PND26, females on PMI 5K96 showed accel-
erated growth, elevated serum leptin, and uteri
that were being stimulated by estrogen
(indicative of the onset of puberty), whereas
the uteri of PMI 5008/5001 females did not
show evidence of estrogen stimulation, and
thus were still prepubertal. In addition, the
first ovulation resulting in pregnancy, marking
the end of puberty and onset of fertility,
occurred earlier in females fed PMI 5K96 than
in females fed PMI 5008/5001. Females fed
PMI 5K96 also showed a greater increase in
uterine weight in response to stimulation by
estradiol in the prepubertal uterotrophic assay,
which is also consistent with developmental
exposure to estrogenic chemicals (Newbold
et al. 2004). Taken together, these findings
suggest a permanent adverse consequence on
the reproductive system in male and female
offspring whose mothers ate the low-
phytoestrogen PMI 5K96 feed resulting from
the elevated estradiol levels during fetal life
[the fetal estrogenization syndrome (FES)]. 
Although there is some evidence that soy
isoflavones can reduce activity of aromatase,
the enzyme that metabolizes androgen to estro-
gen (Adlercreutz et al. 1993), preliminary stud-
ies (vom Saal FS, unpublished data) suggest
that the lower estradiol in high-phytoestrogen–
exposed fetuses is related to a reduction in pro-
duction of the estrogen-binding plasma protein
alphafetoprotein (AFP) in the fetal liver rather
than a decrease in production of aromatase
(primarily present in the fetal mouse brain).
We previously reported that the percent of
total free serum estradiol is constant over a
wide range of total serum estradiol concentra-
tions in rat and mouse serum (Montano et al.
1995). This finding suggests that the difference
in total serum estradiol in fetuses whose moth-
ers were fed low- and high-phytoestrogen–
containing feed, which may be due to a differ-
ence in plasma AFP levels, would result in a
proportional difference in free, biologically
active serum estradiol; this represents about
0.2–0.3% of total serum estradiol in mouse
and rat fetuses (Greenstein 1992; Montano
et al. 1995; vom Saal et al. 1997).
There has been considerable interest in
the hormonal activity of diets that contain soy
phytoestrogens with regard to the potential
for adverse effects in infants (Newbold et al.
2001; Sheehan 1997). Against the back-
ground of very low endogenous estradiol
found in females between birth and the onset
of puberty, a phytoestrogen-rich diet can
stimulate uterine growth and accelerate
puberty (Boettger-Tong et al. 1998; Thigpen
et al. 2003), and administration of genistein
at amounts in soy infant formula to neonatal
mice, against a very low background level of
estradiol, caused uterine cancer in midlife,
similar to effects of the potent estrogenic
drug DES (Newbold et al. 2001). In con-
trast, phytoestrogens can have antagonistic
effects on estradiol when there are very high
levels of estradiol, such as during pregnancy
(Adlercreutz et al. 1993). There is now exten-
sive evidence that chemicals classified as
estrogens can have markedly different activi-
ties at different times in life, in relation to
different background levels of endogenous
estradiol, and different activities in different
tissues. Thus, chemicals such as the drug
tamoxifen, phytoestrogens in soy, and BPA
in plastic are referred to as selective estrogen
receptor modulators (Welshons et al. 2006).
Our findings suggest that the high-phyto-
estrogen content of PMI 5008 feed resulted in a
decrease in fetal serum estradiol relative to the
low-phytoestrogen PMI 5K96 feed. A soy-
based diet can thus have significant beneficial
effects on phenotype in mice by virtue of reduc-
ing fetal serum estradiol, which is protective
against the FES. This finding emphasizes that
the simplistic assumption that a diet with
phytoestrogens will estrogenize fetuses is not
valid with regard to fetal development. In con-
trast, this assumption is clearly correct between
birth and weaning when endogenous estrogen
is very low; lactation is the only time in life
when mammals have evolved to live on milk,
with casein as the sole source of protein and
thus very low exposure to phytoestrogens
regardless of phytoestrogen levels in the mater-
nal diet (Doerge et al. 2006; Franke and Custer
1996). Taken together, these findings suggest
that feeds with different levels of phytoestrogens
may be desirable for use during pregnancy and
lactation as opposed to after weaning, whereas
for studies that involve maintaining female
rodents after the midlife cessation of ovulation,
a different diet composition may be most
appropriate. Clearly, this relatively unstudied
area represents an important research need
(Heindel and vom Saal 2008).
We found that the low-phytoestrogen
PMI 5K96 feed resulted in prediabetic traits of
excess fat and impaired glucose tolerance rela-
tive to the phytoestrogen-rich PMI 5008/5001
feeds, even though all of these diets provide
very similar calories per gram (Table 1).
Metabolic syndrome refers to the clustering of
risk factors for cardiovascular disease and type 2
diabetes, such as impaired glucose metabolism
and insulin resistance, obesity, and hyperten-
sion (Kahn et al. 2001; Liese et al. 1998). The
increasing incidence of these conditions in the
United States and other countries has generated
attention on potential causes, specifically on
events in utero that are associated with pre-
mature mortality from these diseases. The
PMI 5K96-fed mothers produced fetuses that
were significantly lighter at birth relative to
pups produced by soy-fed mothers, but by
shortly after weaning this relationship was
reversed, and by adulthood the animals on the
low-phytoestrogen feed had become obese. 
Additional evidence in support of the
hypothesis that mice fed a low-phytoestrogen
diet throughout life have metabolic syndrome
is provided in another related study in which
CD-1 mice were fed Harlan 8604 soy-based
feed with high-phytoestrogen levels or a soy-
free purified diet by Zeigler (Cederroth et al.
2007). These authors reported that, similar to
our findings, the mice administered the feed
without soy isoflavones were fatter and
showed impaired glucose tolerance, as well as
impaired resistance to cold and reduced activ-
ity levels (Cederroth et al. 2007). 
Conclusions
Additional research will be needed to deter-
mine whether all of these outcomes are caused
by elevated estradiol levels during fetal life.
However, every one of our experiments con-
cerning reproductive end points provided a
comparison between the potential for high
estrogenic activity in soy-based feed to stimu-
late estrogenic responses at the time of data
collection in postnatal life (Thigpen et al.
2003) compared with the predicted outcome
of elevated fetal estradiol on the outcome based
on a large number of published studies on this
subject. Our results did not indicate that the
soy phytoestrogens in PMI 5001 feed after
weaning had an effect on the outcome of any
experiment, although the findings were consis-
tent with the outcome predicted as a result of
increasing estrogen levels during fetal life on
the reproductive system. 
The “fetal basis of adult disease” hypothesis
proposes that endocrine or other metabolic dis-
turbances in the fetus can lead to development
of a phenotype consistent with metabolic syn-
drome. The prediction that developmental
exposure to estradiol is involved in the increase
in postnatal body weight in PMI 5K96-fed
mice, and is thus a newly discovered compo-
nent of the FES, is supported by findings that
neonatal exposure to a low dose of DES signifi-
cantly increased adult body weight relative to
untreated mice in an experiment in which the
mice were maintained on a feed containing
phytoestrogens (Newbold et al. 2005).
Reproductive problems associated with dia-
betes and obesity have generally been assumed
to be secondary to these metabolic disorders. 
In summary, our findings suggest the pos-
sibility of a common etiology for fetal effects
on adult obesity and reproductive disorders,
because all of the findings concerning the
effects of these high- and low-phytoestrogen–
containing feeds are consistent with the
hypothesis that the elevated levels of estradiol
in fetal mice whose mothers consumed a low-
phytoestrogen feed produced the suite of adverse
reproductive outcomes referred to as FES. 
Adverse effects of phytoestrogen-free feed
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